Quest PharmaTech Inc. QPT.V
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · questpharmatech.com
Quest PharmaTech Inc. is a Canadian pharmaceutical company headquartered in Edmonton, Alberta, focused on developing antibody-based immunotherapeutic products for cancer treatment. The company's lead candidate MAb AR9.6 targets MUC16 antigens for potential treatment of pancreatic, colon, leukemia, ovarian, and breast cancers, and it maintains ownership interests in joint ventures including OncoVent in China.
Key ratios
ReturnOnAssets TTM -0.02
ReturnOnAssets 2025 -0.02
ReturnOnAssets 2024 -0.03
ReturnOnAssets 2023 -0.01
ReturnOnEquity TTM -0
ReturnOnEquity 2025 -0.08
ReturnOnEquity 2024 -0.12
ReturnOnEquity 2023 -1.12